Salute e Benessere

General Inception acquires Enable Medicine and announces strategic partnership…

Power of generative biological search Power of generative biological search Enable Medicine harnesses the revolutionary capabilities of AI to guide novel insights into biology and medicine. The platform unlocks the power of generative biological search, which uses cutting-edge AI models to search maps of disease for novel drug targets and indications. The approach prioritizes indexing high quality multimodal cellular data to enable the research community and pharmaceutical industry to...
PR Newswire
12/12/2024

SpliceBio Announces U.S. FDA IND Clearance of SB-007 to Commence Phase 1/2…

"Stargardt disease has been a challenge for the development of gene therapies due to the large size of the ABCA4 gene, and currently has no approved therapies available," said Professor Paul Yang, M.D., Ph.D., Chief of the Paul H. Casey Ophthalmic Genetics Division at Casey Eye Institute at Oregon Health & Science University. "This new therapy utilizes a unique approach to replace the full-size, normal ABCA4 protein at high efficiency, which addresses the root cause of…
PR Newswire
12/12/2024

Breakthrough in Lupus Treatment: Isotopia Partners with LIVEKIDNEY.BIO

This partnership combines LIVEKIDNEY.BIO's pioneering work in lupus treatment with Isotopia's world-class manufacturing capabilities at our state-of-the-art aseptic plant. Our commitment to quality and safety ensures the highest standards in producing a key therapeutic agent for treating lupus. This partnership combines LIVEKIDNEY.BIO's pioneering work in lupus treatment with Isotopia's world-class manufacturing capabilities at our state-of-the-art aseptic plant. Our commitment to quality and...
PR Newswire
12/12/2024

DeerRun Set to Enter the German Market with Smart Treadmills, Offering…

Since its launch, DeerRun has quickly become a leading smart treadmill brand in North America, thanks to its innovative products and the PitPat platform, known as the "Online Olympics Platform." With over 1 million treadmills sold globally, DeerRun engages tens of thousands of users daily in virtual races and fitness challenges on PitPat. Since its launch, DeerRun has quickly become a leading smart treadmill brand inNorth America, thanks to its innovative products and…
PR Newswire
12/12/2024

A public organisation has chosen the Aino SaaS platform

Yet another public organization haschosenAino's SaaS platform. As part of a comprehensive strategy to be more socially sustainable, more productive and gain attraction as an employer, to manage staffing needs and secure the competence supply. Theagreementincludes a total of 600 employees and the Aino SaaS platform is in production-use from the first quarter of 2025. “All Ainos public customers work hard every day to find and to keep employees with the right competence, to...
Nasdaq GlobeNewswire
12/12/2024

Sectra's six-month interim report 2024/2025: Order bookings at a record high

Six-month period: May–October 2024 in figures Six-month period: May–October 2024 in figures Comments from Torbjörn Kronander, President and CEO of Sectra AB"The first half of the year can be summarized as follows: record-breaking order bookings, a continued positive trend for secure communications and significant progress in the transition to selling medical diagnostic imaging as a service. More extensive contracts with customers lead to large variations in order bookings, sales and...
PR Newswire
12/12/2024

HANZA acquires Leden - a billion SEK Finnish manufacturer

With this acquisition, HANZA is expanding its offering in Finland in particular, but also in the Baltics. Among other things, this means increased capacity and expertise in advanced mechanics manufacturing. With this acquisition, HANZA is expanding its offering inFinlandin particular, but also in the Baltics. Among other things, this means increased capacity and expertise in advanced mechanics manufacturing. Summary of the transaction Management comments "The acquisition of...
PR Newswire
12/12/2024

Essential Pharma announces €900 million recapitalisation through a Gyrus Capital…

Essential Pharma announces €900 million recapitalisation through a Gyrus Capital Continuation Vehicle led by AlpInvest and new strategic financing from Sixth StreetProvides significant resources to build on diversified portfolio of established and rare disease medicinesEgham, UK – 12 December 2024– Essential Pharma (“Essential” or “the Company”), an international specialty pharma group focused on ensuring that patients have access to low volume, clinically differentiated, niche...
Nasdaq GlobeNewswire
12/12/2024

ONWARD Medical Ranks in Top 15 Percent Globally for Corporate Sustainability

EcoVadis silver medal recognizes Company's environmental and social impactDemonstrates ongoing commitment to integrating sustainable business practices EINDHOVEN, the Netherlands, Dec.12, 2024(GLOBE NEWSWIRE) -- ONWARD Medical N.V. (Euronext: ONWD), the medical technology company creating innovative spinal cord stimulation therapies to restore movement, function, and independence in people with spinal cord injury (SCI), today announces it has been awarded a silver medal by EcoVadis,...
Nasdaq GlobeNewswire
12/12/2024

Alma Expands Injectables Presence in APAC with Profhilo® Launch in Thailand

The flagship Swiss-based bio-remodeler, Profhilo®, delivers a unique "beneath-the-skin" hyaluronic acid treatment, powered by patented NAHYCO® technology. This advanced formulation provides a prolonged stimulating effect on dermal cells, rejuvenating the skin by improving laxity, skin quality and restoring firmness. The flagship Swiss-based bio-remodeler, Profhilo®, delivers a unique "beneath-the-skin" hyaluronic acid treatment, powered by patented NAHYCO® technology. This…
PR Newswire
12/12/2024

T-cell Malignancies Market Dynamics: Key Insights on Acute Lymphocytic Leukemia…

These malignancies are often more aggressive and harder to treat than B-cell cancers due to their complex biology and resistance to conventional therapies. Symptoms can vary but typically include enlarged lymph nodes, fever, night sweats, and weight loss. Treatment options include chemotherapy, radiation therapy, and novel therapies like CAR T-cell therapy and targeted therapies, which are advancing the understanding and management of these challenging cancers. These malignancies are often…
PR Newswire
11/12/2024

Voting Rights and Shares Capital of the Company

In accordance with articles L.233-8 II of the French Commercial Code and 223-16 of the General Regulation of the French Financial Markets Authority (Autorité des Marchés Financiers)PARIS, Dec.11, 2024(GLOBE NEWSWIRE) --Paris, France, December 11, 2024Market: Euronext Paris / Nasdaq Euronext Compartment: BISIN code: FR0011341205 Nasdaq: NBTX Bloomberg: NANO:FP Reuters: NANO.PA Website:www.nanobiotix.comDateNumber of Shares OutstandingTotal number of voting...
Nasdaq GlobeNewswire
11/12/2024

DBV Confirms Alignment with U.S. FDA on Accelerated Approval Pathway for the…

th, 2024 DBV Confirms Alignment with U.S. FDA on Accelerated Approval Pathway for the Viaskin® Peanut Patch in Toddlers 1 – 3 Years-Old DBV and FDA aligned on key study design elements for the COMFORT Toddlers study in 1 – 3 year-olds, including study size and wear time collection methodology and analysis COMFORT Toddlers study on-track to initiate in 2Q 2025Viaskin Peanut patch BLA submission for the Toddlers indication anticipated for 2H 2026 FDA confirmed criteria for...
Nasdaq GlobeNewswire
11/12/2024

Iron Supplements Market to Reach USD 5.18 Billion by 2028, Driven by Rising…

This growth is fueled by a rising prevalence of iron deficiency-related disorders, including anemia, across various age groups. Additionally, the growing emphasis on preventive healthcare and dietary supplementation is boosting demand for iron supplements worldwide. As consumers become more health-conscious, the adoption of these products is anticipated to expand, particularly in regions with high instances of nutritional deficiencies. This growth is fueled by a rising prevalence of iron...
PR Newswire
11/12/2024

AB Science will host a live webcast on Monday December 16, 2024, from 5.30pm to…

PRESS RELEASEAB SCIENCE WILL HOST A LIVE WEBCAST ON MONDAY DECEMBER 16, 2024 FROM 5.30PM TO 6.30PM CETParis, 11 December, 2024, 6pm CETAB Science SA(Euronext – FR0010557264 – AB) will host a live webcast on Monday December 16, 2024, from 5.30pm to 6.30pm CET. The agenda of this live webcast will be to provide an update on both masitinib and AB8939 platforms.The following attendees will participate to the live webcast: Alain Moussy, co-founder and CEO of AB ScienceOlivier...
Nasdaq GlobeNewswire
11/12/2024

OSE Immunotherapeutics Announces Positive Clinical Progress for Late-Stage…

OSE Immunotherapeutics Announces Positive Clinical Progress for Late-Stage Proprietary Cancer Vaccine Tedopi®ARTEMIA: Clinical trial protocol approved globally. Most countries and sites activated, with full activation expected in H1 2025. First patients enrolled in this international Phase 3 registration study of Tedopi® in monotherapy in second-line Non-Small Cell Lung Cancer (NSCLC).TEDOVA: Completion of patient enrollment in the Phase 2 study of Tedopi® alone or in combination...
Nasdaq GlobeNewswire
11/12/2024

EssilorLuxottica: Disclosure of Share Capital and Voting Rights Outstanding as…

Disclosure of Share Capital and Voting Rights Outstandingas of November 30, 2024(Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité des Marchés Financiers)Paris, France (December 11, 2024 - 6:00 pm)– As of November 30, 2024, shares and voting rights outstanding of EssilorLuxottica, the global leader in the design, manufacture and distribution of ophthalmic lenses, frames and sunglasses, breaks...
Nasdaq GlobeNewswire
11/12/2024

Osteotec appointed as exclusive distributor for Cerapedics in the UK and Ireland

The introduction of these clinically validated solutions underscores Osteotec's mission to enhance surgical outcomes and transform patient care in bone repair. The introduction of these clinically validated solutions underscores Osteotec's mission to enhance surgical outcomes and transform patient care in bone repair. Headquartered inWestminster, Colorado, Cerapedics is a global leader in orthopaedics. Its i-FACTOR portfolio is powered by the proprietary P-15 Osteogenic Cell Binding...
PR Newswire
11/12/2024

Radiotherapy Market to Hit USD 9.62 Billion by 2030 with 4.9% CAGR |…

Browse in-depth TOC on "Radiotherapy Market"310 - Tables56 - Figures312 - Pages Browse in-depth TOC on "Radiotherapy Market" 310 - Tables 56 - Figures 312 - Pages Moreover, in recent years, the market players are also focusing on providing cost-effective radiotherapy systems due to its growing demand amongst various end users in the market. Also, there is an increasing demand for radiotherapy specially EBRT in the emerging markets. All these factors are expected to drive…
PR Newswire
11/12/2024

GNT Pharma Reports Significant Improvements in Stroke Patients Treated with its…

SEOUL, South Korea, Dec. 11, 2024 /PRNewswire/ -- GNT Pharma Co. Ltd, a late-stage pharmaceutical company founded in 1998 with offices in Seoul Korea, Italy and USA, announced today the results of its latest Phase II ('SONIC') and Phase III ('Rodin') clinical trials study showing that stroke patients who received early administration of Nelonemdaz in combination with endovascular thrombectomy, demonstrated significant improvements in outcomes. SEOUL, South Korea , Dec. 11, 2024 ...
PR Newswire
11/12/2024

CRO Services Market Surges to USD 188.54 Billion by 2030, Propelled by 12.6%…

The CRO (Contract Research Organization) services market is primarily driven by the increasing demand for outsourced research and clinical trials due to the rising cost and complexity of in-house research. The growing emphasis on drug development, regulatory compliance, and the need for faster market approval are also key contributors to the market's growth. Additionally, advancements in biotechnology and the surge in personalized medicine fuel demand for specialized CRO services. However, the…
PR Newswire
11/12/2024

Coloplast A/S - Trading in Coloplast shares by board members, executives or…

Please see enclosed pdf. Attachment 11122024_trading_in_shares_GL
Nasdaq GlobeNewswire
11/12/2024

Signant Health Names Krishna Maridi, a Finance Leader with Over 25 Years of…

"I've had the benefit of first-hand experience watching Krishna lead through complex process improvement to make a business operate better for its customers and employees," commented Roger Smith, Signant's chief executive officer. "In an environment where our biopharma and CRO customers seek partners that enable greater precision in service delivery based on analytics, his unique combination of pharmaceutical industry knowledge, broad financial expertise, and global business…
PR Newswire
11/12/2024

Noul and Limbach Gruppe, Germany's top lab chain, to sign an agreement for the…

Noul's CEO, David Lim said, "This agreement is significant in that it is the first contract with a major lab chain in Europe," and that "Noul plans to extend the reach into the European market with all of its test portfolios, beginning with the well-referenced miLab MAL and BCM, and in the near future with the cervical cancer solution recognized by WHO-UNITAID. Securing the most esteemed and high-standard reference customers in Europe will accelerate our expansion into other…
PR Newswire
11/12/2024
Altri  Comunicati